<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
We doubled our mammalian cell culture capacity in Europe! Get More Info

1 min read

Gene Therapy for Rare Disorders U.S., March 7-10, 2022

Date: March 7-10, 2022

Location: Boston, MA (Hynes Convention Center)

Event Website: genetherapy-conference.com

Program Organizer: Hanson Wade




AGC Biologics team members available to meet or chat:

Detra Gilnatsis Detra Gilnatsis
Luca Alberici Luca Alberici
Person Giuliana Vallanti

Contact us to schedule a meeting


About the Event

Gene Therapy for Rare Disorders is dedicated to overcoming the unique drug development challenges encountered in transforming gene therapy concepts into reality for rare disease patients in need.

As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, Gene Therapy for Rare Disorders 2022 will provide in-depth insights from experts who know how to drive clinical progress, optimize manufacturing, and demonstrate the value of gene therapy products to regulators, payers, and patients.

Across four days, this meeting will unite 500+ leading experts in Boston from innovative biotechs, large pharma, academia, and key service provider companies, delivering actionable insights and valuable networking opportunities to accelerate gene therapy progress.